MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma

European Journal of Cancer

Volumn 53, Issue , 2016, Pages 25-32

  Mirzaei, Hamed ^a   Gholamin, Sharareh ^d   Shahidsales, Soodabeh ^b   Sahebkar, Amirhossein ^a   Jafaari, Mahmoud Reza ^a   Mirzaei, Hamid Reza ^c   Hassanian, Seyed Mahdi ^a   Avan, Amir ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Circulating marker; Melanoma; MiRNA

Indexed keywords

MICRORNA; MICRORNA 205; MICRORNA 221; MICRORNA 222; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; EXOSOME; HUMAN; LUCIFERASE ASSAY; MELANOMA; MELANOMA CELL; ONCOGENE N RAS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROGNOSIS; SKIN NEOPLASMS; UPREGULATION;

BIOMARKERS, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; EXOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICRORNAS; PROGNOSIS; SKIN NEOPLASMS; UP-REGULATION;

EID: 84949579802     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.10.009     Document Type: Review

References (109)

1. J.R. Wong, J.K. Harris, C. Rodriguez-Galindo, and K.J. Johnson Incidence of childhood and adolescent melanoma in the United States 1973-2009 Pediatrics 131 5 2013 846 854
2. J. Yan, C. Tingey, R. Lyde, T.C. Gorham, D.K. Choo, A. Muthumani, and et al. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model Cancer Gene Ther 21 12 2014 507 517
3. S. Tiwary, M. Preziosi, P.G. Rothberg, N. Zeitouni, N. Corson, and L. Xu ERBB3 is required for metastasis formation of melanoma cells Oncogenesis 3 2014 e110
4. M. Aris, and M.M. Barrio Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment Front Immunol 6 2015 46
5. T. Tarver Cancer facts & figures 2012. American Cancer Society (ACS) 2012 American Cancer Society Atlanta, GA 66 p., pdf. Available from: Journal of Consumer Health on the Internet. 2012;16(3):366-367
6. V. Sun, W. Zhou, S. Majid, M. Kashani-Sabet, and A. Dar MicroRNA-mediated regulation of melanoma Br J Dermatol 171 2 2014 234 241
7. H. Xie, L. Lee, S. Caramuta, A. Höög, N. Browaldh, V. Björnhagen, and et al. MicroRNA expression patterns related to Merkel cell polyomavirus infection in human Merkel cell carcinoma J Invest Dermatol 134 2 2014 507 517
8. M. Acunzo, G. Romano, D. Wernicke, and C.M. Croce MicroRNA and cancer - a brief overview Adv Biol Regul 57 2015 1 9
9. J. Sandoval, A. Díaz-Lagares, R. Salgado, O. Servitje, F. Climent, P.L. Ortiz-Romero, and et al. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma J Invest Dermatol 135 4 2015 1128 1137
10. R.E. Bell, M. Khaled, D. Netanely, S. Schubert, T. Golan, A. Buxbaum, and et al. Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1 J Invest Dermatol 134 2 2014 441 451
11. S. Noguchi, M. Kumazaki, Y. Yasui, T. Mori, N. Yamada, and Y. Akao MicroRNA-203 regulates melanosome transport and tyrosinase expression in melanoma cells by targeting kinesin superfamily protein 5b J Invest Dermatol 134 2 2014 461 469
12. S. Seton-Rogers Non-coding RNA: editing suppresses melanoma progression Nat Rev Cancer 15 4 2015 198
13. M.L. Hartman, and M. Czyz Pro-survival role of MITF in melanoma J Invest Dermatol 135 2 2015 352 358
14. M. Maftouh, A. Avan, N. Funel, A.E. Frampton, H. Fiuji, S. Pelliccioni, and et al. miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells Nucleosides Nucleotides Nucleic Acids 33 2014 384 393
15. L.T. Bemis, R. Chen, C.M. Amato, E.H. Classen, S.E. Robinson, D.G. Coffey, and et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines Cancer Res 68 5 2008 1362 1368
16. Y. Deng, H. Deng, F. Bi, J. Liu, L.T. Bemis, D. Norris, and et al. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines Int J Biol Sci 7 1 2011 133
17. M. Maftouh, A. Avan, E. Galvani, G.J. Peters, and E. Giovannetti Molecular mechanisms underlying the role of microRNAs in resistance to epidermal growth factor receptor-targeted agents and novel therapeutic strategies for treatment of non-small-cell lung cancer Crit Rev Oncog 18 2013 317 326
18. S. Goswami, R.S. Tarapore, J.J. TeSlaa, Y. Grinblat, V. Setaluri, and V.S. Spiegelman MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein J Biol Chem 285 27 2010 20532 20540
19. B.S. Haflidadottir, K. Bergsteinsdottir, C. Praetorius, and E. Steingrimsson miR-148 regulates Mitf in melanoma cells PLoS One 5 7 2010 e11574
20. M.F. Segura, D. Hanniford, S. Menendez, L. Reavie, X. Zou, S. Alvarez-Diaz, and et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor Proc Natl Acad Sci U S A 106 6 2009 1814 1819
21. N. Pencheva, H. Tran, C. Buss, D. Huh, M. Drobnjak, K. Busam, and et al. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis Cell 151 5 2012 1068 1082
22. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 1 2000 57 70
23. D.W. Muller, and A.K. Bosserhoff Integrin β3 expression is regulated by let-7a miRNA in malignant melanoma Oncogene 27 52 2008 6698 6706
24. J.F. Solus, and S. Kraft Ras, Raf, and MAP kinase in melanoma Adv Anat Pathol 20 4 2013 217 226
25. D.W. Mueller, M. Rehli, and A.K. Bosserhoff miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma J Invest Dermatol 129 7 2009 1740 1751
26. A. Bhattacharya, U. Schmitz, O. Wolkenhauer, M. Schönherr, Y. Raatz, and M. Kunz Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma Oncogene 32 26 2012 3175 3183
27. F. Felicetti, M.C. Errico, L. Bottero, P. Segnalini, A. Stoppacciaro, M. Biffoni, and et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms Cancer Res 68 8 2008 2745 2754
28. O. Igoucheva, and V. Alexeev MicroRNA-dependent regulation of cKit in cutaneous melanoma Biochem Biophys Res Commun 379 3 2009 790 794
29. W. Li, A. Sanki, R.Z. Karim, J.F. Thompson, C. Soon Lee, L. Zhuang, and et al. The role of cell cycle regulatory proteins in the pathogenesis of melanoma Pathology 38 4 2006 287 301
30. R.D. Carvajal, C.R. Antonescu, J.D. Wolchok, P.B. Chapman, R.-A. Roman, J. Teitcher, and et al. KIT as a therapeutic target in metastatic melanoma JAMA 305 22 2011 2327 2334
31. Y.-N. Wang, Y. Yamamoto, and F. Furukawa Potential biomarkers for malignant melanoma World J Gastroenterol 2 4 2013 44 50
32. A.A. Dar, S. Majid, D. de Semir, M. Nosrati, V. Bezrookove, and M. Kashani-Sabet miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein J Biol Chem 286 19 2011 16606 16614
33. I. Elson-Schwab, A. Lorentzen, and C.J. Marshall MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion PLoS One 5 10 2010
34. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
35. E. Penna, F. Orso, D. Cimino, E. Tenaglia, A. Lembo, E. Quaglino, and et al. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C EMBO J 30 10 2011 1990 2007
36. M.F. Segura, H.S. Greenwald, D. Hanniford, I. Osman, and E. Hernando MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy Carcinogenesis 33 10 2012 1823 1832
37. H. Kanemaru, S. Fukushima, J. Yamashita, N. Honda, R. Oyama, A. Kakimoto, and et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker J Dermatol Sci 61 3 2011 187 193
38. S. Achberger, W. Aldrich, R. Tubbs, J.W. Crabb, A.D. Singh, and P.L. Triozzi Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease Mol Immunol 58 2 2014 182 186
39. M.N. Aftab, M.E. Dinger, and R.J. Perera The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma Arch Biochem Biophys 563 2014 60 70
40. V. Tembe, S.J. Schramm, M.S. Stark, E. Patrick, V. Jayaswal, Y.H. Tang, and et al. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis Pigment Cell Melanoma Res. 28 3 2015 254 266
41. K. Teshima, M. Nara, A. Watanabe, M. Ito, S. Ikeda, Y. Hatano, and et al. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma Oncogene 33 17 2014 2191 2203
42. Q. Li, Y. Yao, G. Eades, Z. Liu, Y. Zhang, and Q. Zhou Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer Oncogene 33 20 2014 2589 2600
43. G. Di Leva, M. Garofalo, and C.M. Croce MicroRNAs in cancer Ann Rev Pathol 9 2014 287
44. A. Hata, and J. Lieberman Dysregulation of microRNA biogenesis and gene silencing in cancer Sci Signal 8 368 2015 re3-re
45. E.B. Friedman, S. Shang, E. de Miera, J.U. Fog, M.W. Teilum, M.W. Ma, and et al. Serum microRNAs as biomarkers for recurrence in melanoma J Transl Med 10 1 2012 155 161
46. N.H. Fleming, J. Zhong, I.P. da Silva, E. Vega-Saenz de Miera, B. Brady, S.W. Han, and et al. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients Cancer 121 1 2015 51 59
47. D.B. Johnson, and R.J. Sullivan Biomarkers in melanoma: where are we now? Melanoma Manag 1 2 2014 139 150
48. J. Schultz, P. Lorenz, G. Gross, S. Ibrahim, and M. Kunz MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth Cell Res 18 5 2008 549 557
49. T.Y. Fu, C.C. Chang, C.T. Lin, C.H. Lai, S.Y. Peng, Y.J. Ko, and et al. Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells Exp Cell Res 317 4 2011 445 451
50. L. He, J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, and et al. A microRNA polycistron as a potential human oncogene Nature 435 7043 2005 828 833
51. L. Sun, Y. Yao, B. Liu, Z. Lin, L. Lin, M. Yang, and et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1 Oncogene 31 4 2011 432 445
52. I. Satzger, A. Mattern, U. Kuettler, D. Weinspach, B. Voelker, A. Kapp, and et al. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma Int J Cancer 126 11 2010 2553 2562
53. G. Mattia, M.C. Errico, F. Felicetti, M. Petrini, L. Bottero, L. Tomasello, and et al. Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma Pigment Cell Melanoma Res 24 5 2011 953 965
54. C.H. Yang, J. Yue, S.R. Pfeffer, C.R. Handorf, and L.M. Pfeffer MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells J Biol Chem 286 45 2011 39172 39178
55. S.E. Martin del Campo, N. Latchana, K.M. Levine, V.P. Grignol, E.T. Fairchild, A.C. Jaime-Ramirez, and et al. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor PLoS One 10 1 2015 e0115919
56. T.T. Zhang, Y. Sun, C.W. Jia, S.N. Yu, Z.H. Lu, and J. Chen Target prediction and verification of miR-27a in pancreatic cancer Zhonghua Bing Li Xue Za Zhi Chin J Pathol 42 6 2013 392 396
57. D.B. Shi, A.Y. Xing, C. Gao, and P. Gao Expression of microRNA-100 in human gastric cancer Zhonghua Bing Li Xue Za Zhi Chin J Pathol 42 1 2013 15 19
58. L. Jin, W.L. Hu, C.C. Jiang, J.X. Wang, C.C. Han, P. Chu, and et al. MicroRNA-149∗, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma Proc Natl Acad Sci U S A 108 38 2011 15840 15845
59. K.L. Streicher, W. Zhu, K.P. Lehmann, R.W. Georgantas, C.A. Morehouse, P. Brohawn, and et al. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth Oncogene 31 12 2012 1558 1570
60. C. Luo, P.W. Tetteh, P.R. Merz, E. Dickes, A. Abukiwan, A. Hotz-Wagenblatt, and et al. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes J Invest Dermatol 133 3 2013 768 775
61. K. Sakurai, C. Furukawa, T. Haraguchi, K. Inada, K. Shiogama, T. Tagawa, and et al. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers Cancer Res 71 5 2011 1680 1689
62. P. Leidinger, A. Keller, A. Borries, J. Reichrath, K. Rass, S.U. Jager, and et al. High-throughput miRNA profiling of human melanoma blood samples BMC Cancer 10 1 2010 262
63. M. Kitago, S.R. Martinez, T. Nakamura, M.-S. Sim, and D.S. Hoon Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma Clin Cancer Res 15 9 2009 2988 2994
64. D.S. Hoon, M. Kitago, J. Kim, T. Mori, A. Piris, K. Szyfelbein, and et al. Molecular mechanisms of metastasis Cancer Metastasis Rev 25 2 2006 203 220
65. P. Fasanaro, Y. D'Alessandra, V. Di Stefano, R. Melchionna, S. Romani, G. Pompilio, and et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3 J Biol Chem 283 23 2008 15878 15883
66. M.E. Crosby, R. Kulshreshtha, M. Ivan, and P.M. Glazer MicroRNA regulation of DNA repair gene expression in hypoxic stress Cancer Res 69 3 2009 1221 1229
67. A.M. Cheng, M.W. Byrom, J. Shelton, and L.P. Ford Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis Nucleic Acids Res 33 4 2005 1290 1297
68. P. Fasanaro, S. Greco, M. Lorenzi, M. Pescatori, M. Brioschi, R. Kulshreshtha, and et al. An integrated approach for experimental target identification of hypoxia-induced miR-210 J Biol Chem 284 50 2009 35134 35143
69. A.M. Poenitzsch Strong, V. Setaluri, and V.S. Spiegelman microRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma Arch Biochem Biophys 563 2014 118 124
70. A. Gaziel-Sovran, M.F. Segura, R. Di Micco, M.K. Collins, D. Hanniford, E. Vega-Saenz de Miera, and et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis Cancer Cell 20 1 2011 104 118
71. M.F. Segura, I. Belitskaya-Lévy, A.E. Rose, J. Zakrzewski, A. Gaziel, D. Hanniford, and et al. Melanoma microRNA signature predicts post-recurrence survival Clin Cancer Res 16 5 2010 1577 1586
72. Q. Wu, H. Jin, Z. Yang, G. Luo, Y. Lu, K. Li, and et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2 Biochem Biophys Res Commun 392 3 2010 340 345
73. M. Ghisi, A. Corradin, K. Basso, C. Frasson, V. Serafin, S. Mukherjee, and et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150 Blood 117 26 2011 7053 7062
74. M. Thomas, K. Lange-Grünweller, U. Weirauch, D. Gutsch, A. Aigner, A. Grünweller, and et al. The proto-oncogene Pim-1 is a target of miR-33a Oncogene 31 7 2011 918 928
75. D. Cirera-Salinas, M. Pauta, R.M. Allen, A.G. Salerno, C.M. Ramírez, A. Chamorro-Jorganes, and et al. Mir-33 regulates cell proliferation and cell cycle progression Cell Cycle 11 5 2012 922 933
76. M. Sachdeva, S. Zhu, F. Wu, H. Wu, V. Walia, S. Kumar, and et al. p53 represses c-Myc through induction of the tumor suppressor miR-145 Proc Natl Acad Sci 106 9 2009 3207 3212
77. N. Felli, F. Felicetti, A.M. Lustri, M.C. Errico, L. Bottero, A. Cannistraci, and et al. miR-126&126∗restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma PLoS One 8 2 2013 e56824
78. C. Margue, D. Philippidou, S.E. Reinsbach, M. Schmitt, I. Behrmann, and S. Kreis New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion PLoS One 8 9 2013 e73473
79. J. Chen, H.E. Feilotter, G.C. Pare, X. Zhang, J.G. Pemberton, C. Garady, and et al. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma Am J Pathol 176 5 2010 2520 2529
80. S. Noguchi, T. Mori, Y. Otsuka, N. Yamada, Y. Yasui, J. Iwasaki, and et al. Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells J Biol Chem 287 15 2012 11769 11777
81. S. Liu, S.M. Kumar, H. Lu, A. Liu, R. Yang, A. Pushparajan, and et al. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-kappaB1-Snail1 pathway in melanoma J Pathol 226 1 2012 61 72
82. T. Nguyen, C. Kuo, M.B. Nicholl, M.S. Sim, R.R. Turner, D.L. Morton, and et al. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma Epigenetics Off J DNA Methylation Soc 6 3 2011 388 394
83. I.A. Asangani, P.W. Harms, L. Dodson, M. Pandhi, L.P. Kunju, C.A. Maher, and et al. Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma Oncotarget 3 9 2012 1011 1025
84. M. Kim, J.D. Gans, C. Nogueira, A. Wang, J.-H. Paik, B. Feng, and et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene Cell 125 7 2006 1269 1281
85. T.H. Thai, D.P. Calado, S. Casola, K.M. Ansel, C. Xiao, Y. Xue, and et al. Regulation of the germinal center response by microRNA-155 Science 316 5824 2007 604 608
86. L. Levati, E. Alvino, E. Pagani, D. Arcelli, P. Caporaso, S. Bondanza, and et al. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155 Int J Oncol 35 2 2009 393 400
87. G. Zhuang, X. Wu, Z. Jiang, I. Kasman, J. Yao, Y. Guan, and et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway EMBO J 31 17 2012 3513 3523
88. H. Peinado, M. Alečković, S. Lavotshkin, I. Matei, B. Costa-Silva, G. Moreno-Bueno, and et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET Nat Med 18 6 2012 883 891
89. D. Xiao, J. Ohlendorf, Y. Chen, D.D. Taylor, S.N. Rai, S. Waigel, and et al. Identifying mRNA, microRNA and protein profiles of melanoma exosomes PLoS One 7 10 2012 e46874
90. B.N. Hannafon, and W.-Q. Ding Intercellular communication by exosome-derived microRNAs in cancer Int J Mol Sci 14 7 2013 14240 14269
91. G. Hu, K.M. Drescher, and X. Chen Exosomal miRNAs: biological properties and therapeutic potential Non-Coding RNA 3 2012 56
92. D.D. Taylor, and C. Gercel-Taylor MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynaecol Oncol 110 1 2008 13 21
93. G.H. Kloecker, G. Rabinowits, C. Gercel-Taylor, J.M. Day, and D.D. Taylor Exosomal microRNA: a diagnostic marker for lung cancer Clin Lung Cancer 9 5 2008 295
94. G. Rabinowits, C. Gerçel-Taylor, J.M. Day, D.D. Taylor, and G.H. Kloecker Exosomal microRNA: a diagnostic marker for lung cancer Clin Lung Cancer 10 1 2009 42 46
95. S. Nana-Sinkam, and C. Croce Clinical applications for microRNAs in cancer Clin Pharmacol Ther 93 1 2012 98 104
96. J. Hayes, P.P. Peruzzi, and S. Lawler MicroRNAs in cancer: biomarkers, functions and therapy Trends in Mol Med 20 8 2014 460 469
97. H. Schwarzenbach, N. Nishida, G.A. Calin, and K. Pantel Clinical relevance of circulating cell-free microRNAs in cancer Nat Rev Clin Oncol 11 3 2014 145 156
98. J.C. Willis, and G.M. Lord Immune biomarkers: the promises and pitfalls of personalized medicine Nat Rev Immunol 15 5 2015 323 329
99. N.J. Johnston miRNA regulation of programmed cell death-1 in T cells: potential prognostic and therapeutic markers in melanoma 2014
100. C. Huynh, M. Segura, A. Gaziel-Sovran, S. Menendez, F. Darvishian, L. Chiriboga, and et al. Efficient in vivo microRNA targeting of liver metastasis Oncogene 30 12 2010 1481 1488
101. H.F. Wang, H. Chen, M.W. Ma, J.A. Wang, T.T. Tang, L.S. Ni, and et al. miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule Oncol Rep 30 1 2013 520 526
102. J. Chen, X. Zhang, C. Lentz, M. Abi-Daoud, G.C. Paré, X. Yang, and et al. miR-193b regulates Mcl-1 in melanoma Am J Pathol 179 5 2011 2162 2168
103. L.T. Lam, X. Lu, H. Zhang, R. Lesniewski, S. Rosenberg, and D. Semizarov A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax) Mol Cancer Ther 9 11 2010 2943 2950
104. A.A. Dar, S. Majid, C. Rittsteuer, D. de Semir, V. Bezrookove, S. Tong, and et al. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression J Natl Cancer Inst 105 6 2013 433 442
105. Y. Xu, T. Brenn, E. Brown, V. Doherty, and D. Melton Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors Br J Cancer 106 3 2012 553 561
106. G.J. Hurteau, S.D. Spivack, and G.J. Brock Report potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR Cell Cycle 5 17 2006 1951 1956
107. D. Yan, X. Zhou, X. Chen, D.N. Hu, X.D. Dong, J. Wang, and et al. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met Invest Ophthalmol Vis Sci 50 4 2009 1559 1565
108. J. Mazar, D. Khaitan, D. DeBlasio, C. Zhong, S.S. Govindarajan, S. Kopanathi, and et al. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma PLoS One 6 9 2011 e24922
109. S.N. Reuland, S.M. Smith, L.T. Bemis, N.B. Goldstein, A.R. Almeida, K.A. Partyka, and et al. MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD) J Invest Dermatol 133 5 2013 1286 1293